IRADIMED CORPORATION — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$84M
Cost of Revenue
$19M
Gross Profit
$64M
R&D
$3M
D&A
$1M
Operating Income
$26M
EBITDA
$27M
Interest Income
$2M
Other Income/Expense
$205K
Pretax Income
$28M
Tax Provision
$6M
Net Income
$22M
Gross Margin
76.7%
Operating Margin
31.2%
Net Margin
26.8%
Effective Tax Rate
20.7%
Deferred Tax Assets
$94K
Deferred Tax Liabilities
$954K
Tax Credit Carryforwards
—
NOL Carryforwards
—
ETR (Continuing Operations)
20.7%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.5%
ETR Foreign Differential (pp)
—
Operating Lease Cost
$489K
Revenue YoY Variation
14.4%
Income YoY Variation
19.0%